Variational AI inks drug discovery deal with Merck worth up to $349-million

Retrieved on: 2025-09-23 11:32:45

Tags for this article:

Cybernetics

Insilico Medicine

Biotechnology companies

Pharmacy

Merck & Co.

Generative artificial intelligence

Artificial intelligence

Isomorphic Labs

Merck Group

Pharmaceutical industry

Handol Kim

Click the tags to see associated articles and topics

Variational AI inks drug discovery deal with Merck worth up to $349-million. View article details on hiswai:

Excerpt

The most advanced AI drug developer is Boston-based Insilico Medicine Inc., whose drug rentoserib, which targets a chronic lung disease, was shown to ...

Article found on: www.theglobeandmail.com

View Original Article